Post-Exposure Therapeutic Efficacy of COX-2 Inhibition Against Burkholderia Pseudomallei

PLoS Neglected Tropical Diseases - United States
doi 10.1371/journal.pntd.0002212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Antibacterial Activity of Chitosan Against Burkholderia Pseudomallei

MicrobiologyOpen
Microbiology
2017English

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Functional Characterization and Evaluation of in Vitro Protective Efficacy of Murine Monoclonal Antibodies BURK24 and BURK37 Against Burkholderia Pseudomallei

PLoS ONE
Multidisciplinary
2014English

Survival of Burkholderia Pseudomallei in Water

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2008English

Viscum Album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA

PLoS ONE
Multidisciplinary
2015English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation

Trends in Pharmacological Sciences
ToxicologyPharmacology
2014English

Evolution of Burkholderia Pseudomallei in Recurrent Melioidosis

PLoS ONE
Multidisciplinary
2012English

In Vitro and in Vivo Studies of Monoclonal Antibodies With Prominent Bactericidal Activity Against Burkholderia Pseudomallei and Burkholderia Mallei

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy